Acute Kidney Injury (AKI) Disease Treatment Market - Forecasts From 2019 To 2024

96 pages
Published on : May 2019
Report Code : KSI061612284


The acute kidney injury (AKI) disease treatment market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. The major drivers driving the growth of the global acute kidney injury (AKI) disease treatment market include growing elderly population, the prevalence of chronic diseases, and a growing number of acute care admissions and emergency department admissions leading to ICU admission. North America and Europe are expected to hold a significant market share due to the high disease prevalence and other chronic disease prevalence which may lead to the acute kidney disease while the Asia Pacific with Japan, having the maximum geriatric population in the world is expected to be the fastest growing. In addition, rising health awareness among people, especially in the developing countries will lead to frequent checkups, emanating the market growth owing to early disease detection followed by treatment during the forecast period and beyond.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the acute kidney injury (AKI) disease treatment value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the acute kidney injury (AKI) disease treatment market.

Major industry players profiled as part of the report are Nipro Corporation, NIKKISO AMERICA, INC., AM-Pharma, CardioRenal Systems, Inc., Angion Biomedica Corp. and among others.


The acute kidney injury (AKI) disease treatment market has been analyzed through following segments:

By Diagnosis

Urine Tests

Blood Tests

Glomerular Filtration Rate (GFR)

Imaging Tests

Kidney Biopsy


By Treatment


RenalGuard Therapy

Treatment for symptoms and complications


By Geography

North America






South America








United Kingdom




Middle East and Africa

Saudi Arabia




Asia Pacific



South Korea




Target audience




Service Providers

Government Agencies

Research Organizations


Key insights offered

What will be the acute kidney injury (AKI) disease treatment market size from 2017 to 2023?

How are the major drivers and restraints affecting the acute kidney injury (AKI) disease treatment market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.